본문 바로가기
KERD
논문KCI 등재

순환종양세포

Circulating Tumor Cells in Breast Cancer

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Circulating tumor cells (CTCs) is tumor cells that circulate in the bloodstream in patients with malignant tumors. Detecting CTCs is considered as a valuable modality as prognostic and predictive markers in patients with breast cancer. There are potential roles of CTCs for prediction of responsiveness of systemic chemotherapy by serial assay of changing patterns of CTCs number. Analysis of CTCs may provide crucial biological information for selection of optimal targeted agents. In this article, we will review and discuss potential roles and clinical applications of CTCs in patients with breast cancer.

Abstract

Circulating tumor cells (CTCs) is tumor cells that circulate in the bloodstream in patients with malignant tumors. Detecting CTCs is considered as a valuable modality as prognostic and predictive markers in patients with breast cancer. There are potential roles of CTCs for prediction of responsiveness of systemic chemotherapy by serial assay of changing patterns of CTCs number. Analysis of CTCs may provide crucial biological information for selection of optimal targeted agents. In this article, we will review and discuss potential roles and clinical applications of CTCs in patients with breast cancer.

참고문헌 (23)

  1. Wicha MS, "Circulating tumor cells: not all detected cells are bad and not all bad cells are detected", J Clin Oncol, 29, pp.1508~1511 (2011)
  2. Cristofanilli M, "Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer", J Clin Oncol, 23, pp.1420~1430 (2005)
  3. Smerage JB, "The prognostic implications of circulating tumor cells in patients with breast cancer", Cancer Invest, 26, pp.109~114 (2008)
  4. Stathopoulou A, "Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance", J Clin Oncol, 20, pp.3404~3412 (2002)
  5. Xenidis N, "Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer", Ann Oncol, 14, pp.849~855 (2003)
  6. Pachmann K, "An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer", J Cancer Res Clin Oncol, 134, pp.59~65 (2008)
  7. Ross AA, "Minimal residual disease in solid tumor malignancies: a review", J Hematother, 7, pp.9~18 (1998)
  8. Pachmann K, "Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse", J Clin Oncol, 26, pp.1208~1215 (2008)
  9. Pachmann K, "Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring", Breast Cancer Res, 7, pp.R975~R979 (2005)
  10. Harris L, "American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer", J Clin Oncol, 25, pp.5287~5312 (2007)
  11. Tan DS, "Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development", Cancer J, 15, pp.406~420 (2009)
  12. Burstein HJ, "Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer", J Clin Oncol, 28, pp.1301~1307 (2010)
  13. Gianni L, "Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer", J Clin Oncol, 28, pp.1131~1137 (2010)
  14. Baselga J, "Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy", J Clin Oncol, 28, pp.1138~1144 (2010)
  15. Suzuki H, "Interfocal heterogeneity of PTEN", MMAC1 gene alterations in multiple metastatic prostate cancer tissues, 1998, pp.58, 204~209
  16. Xenidis N, "Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients", J Clin Oncol, 24, pp.3756~3762 (2006)
  17. Meng S, "Circulating tumor cells in patients with breast cancer dormancy", Clin Cancer Res, 10, pp.8152~8162 (2004)
  18. Pachmann K, "Longtime recirculating tumor cells in breast cancer patients", Clin Cancer Res, 11, pp.5657~ (2005)
  19. Amadori A, "Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions", Oncology, 76, pp.375~386 (2009)
  20. Dontu G, "Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia", J Mammary Gland Biol Neoplasia, 10, pp.75~86 (2005)
  21. Hyun KA, "Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients", Biosens Bioelectron, 40, pp.206~212 (2013)
  22. Moon HS, "Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP)", Lab Chip, 11, pp.1118~1125 (2011)
  23. 김승일, "Circulating Tumor Cells: Detection Methods and Potential Clinical Application in Breast Cancer", Journal of Breast Cancer, 13(2), pp.125~131 (2010), 한국유방암학회

관련 논문AI추천

이 간행물의 다른 논문 (8건)